KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 153 filers reported holding KRYSTAL BIOTECH INC in Q3 2022. The put-call ratio across all filers is 3.48 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,924 | -1.2% | 189 | 0.0% | 0.00% | – |
| Q2 2023 | $22,189 | +54.8% | 189 | +5.6% | 0.00% | – |
| Q1 2023 | $14,331 | -5.8% | 179 | -6.8% | 0.00% | – |
| Q4 2022 | $15,210 | -10.5% | 192 | -20.0% | 0.00% | – |
| Q3 2022 | $17,000 | -37.0% | 240 | -40.9% | 0.00% | – |
| Q2 2022 | $27,000 | -40.0% | 406 | -39.5% | 0.00% | – |
| Q1 2022 | $45,000 | -22.4% | 671 | -19.6% | 0.00% | – |
| Q4 2021 | $58,000 | +866.7% | 835 | +659.1% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 110 | +17.0% | 0.00% | – |
| Q2 2021 | $6,000 | -62.5% | 94 | -54.1% | 0.00% | – |
| Q1 2021 | $16,000 | +33.3% | 205 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +33.3% | 205 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | +12.5% | 205 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
| S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
| Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
| First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
| Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
| Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
| Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
| Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
| Artal Group S.A. | 400,000 | $31,688 | 1.77% |
| Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |